Cellebrite DI Ltd (NASDAQ: CLBT) kicked off on Monday, up 3.38% from the previous trading day, before settling in for the closing price of $19.23. Over the past 52 weeks, CLBT has traded in a range of $10.24-$26.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Technology sector saw sales topped by 19.94%. While this was happening, its average annual earnings per share was recorded 122.19%. With a float of $93.41 million, this company’s outstanding shares have now reached $234.52 million.
The extent of productivity of a business whose workforce counts for 1167 workers is very important to gauge. In terms of profitability, gross margin is 84.4%, operating margin of 14.19%, and the pretax margin is -68.79%.
Cellebrite DI Ltd (CLBT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Software – Infrastructure Industry. The insider ownership of Cellebrite DI Ltd is 55.11%, while institutional ownership is 41.71%. The most recent insider transaction that took place on Mar 19 ’25, was worth 296,920. Before that another transaction happened on Mar 17 ’25, when Company’s Officer proposed sale 200,000 for $18.25, making the entire transaction worth $3,650,000.
Cellebrite DI Ltd (CLBT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 122.19% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Take a look at Cellebrite DI Ltd’s (CLBT) current performance indicators. Last quarter, stock had a quick ratio of 1.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.87. Likewise, its price to free cash flow for the trailing twelve months is 38.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
The latest stats from [Cellebrite DI Ltd, CLBT] show that its last 5-days average volume of 1.1 million was inferior to 1.96 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 96.33%. Additionally, its Average True Range was 0.86.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 36.62%, which indicates a significant decrease from 98.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.28% in the past 14 days, which was lower than the 45.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.08, while its 200-day Moving Average is $17.72. Now, the first resistance to watch is $20.03. This is followed by the second major resistance level at $20.19. The third major resistance level sits at $20.44. If the price goes on to break the first support level at $19.63, it is likely to go to the next support level at $19.38. The third support level lies at $19.22 if the price breaches the second support level.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
The company with the Market Capitalisation of 4.76 billion has total of 239,470K Shares Outstanding. Its annual sales at the moment are 401,200 K in contrast with the sum of -283,010 K annual income. Company’s last quarter sales were recorded 109,050 K and last quarter income was 19,270 K.
